Alambic Investment Management, L.P. - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2020$114,000
-50.9%
54,164
-11.7%
1.25%
+114.8%
Q2 2020$232,000
+98.3%
61,364
-0.6%
0.58%
+105.7%
Q1 2020$117,000
-52.6%
61,764
-47.8%
0.28%
+36.7%
Q4 2019$247,000
+135.2%
118,364
+170.2%
0.21%
+162.0%
Q3 2019$105,000
+59.1%
43,803
+106.9%
0.08%
+92.7%
Q2 2019$66,00021,1700.04%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q3 2020
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$12,497,00013.66%
Ikarian Capital, LLC 3,392,787$6,412,0000.48%
NEA Management Company, LLC 4,141,308$7,827,0000.41%
Alambic Investment Management, L.P. 61,764$117,0000.28%
KNOTT DAVID M 181,800$344,0000.22%
683 Capital Management, LLC 917,942$1,736,0000.10%
Hudson Bay Capital Management LP 1,409,419$2,664,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 388,309$734,0000.06%
&PARTNERS 15,000$28,0000.04%
Diversified Trust Co 198,534$375,0000.02%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders